Serum IL-8 and VEGFA are Two Promising Diagnostic Biomarkers of Asthma-COPD Overlap Syndrome

References

• FabbriLM, RomagnoliM, CorbettaL, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:418–424. doi:10.1164/rccm.200203-183OC12426229
   PubMed Web of Science ®Google Scholar
• O’DonnellR, BreenD, WilsonS, DjukanovicR. Inflammatory cells in the airways in COPD. Thorax. 2006;61(5):448–454. doi:10.1136/thx.2004.02446316648353
   PubMed Web of Science ®Google Scholar
• AlshabanatA, ZafariZ, AlbanyanO, et al. Asthma and COPD Overlap Syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065. doi:10.1371/journal.pone.013606526336076
   PubMed Web of Science ®Google Scholar
• BellantiJA, SettipaneRA. For the patient. The asthma-COPD overlap syndrome (ACOS): is it asthma? Is it COPD? Or is it both? Allergy Asthma Proc. 2015;36(1):87. doi:10.2500/aap.2015.36.3815
   PubMed Web of Science ®Google Scholar
• BellMC, BusseWW. Is it asthma or is it COPD: the overlap syndrome. J Allergy Clin Immunol Pract. 2015;3(4):641–642. doi:10.1016/j.jaip.2014.11.00326164580
   PubMed Web of Science ®Google Scholar
• PostmaDS, RabeKF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373(13):1241–1249. doi:10.1056/NEJMra141186326398072
   PubMed Web of Science ®Google Scholar
• Vaz FragosoCA, MurphyTE, AgogoGO, AlloreHG, McAvayGJ. Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization.nt. J Chron Obstruct Pulmon Dis. 2017;12(3):517–527. doi:10.2147/COPD.S121223
   Web of Science ®Google Scholar
• CosioBG, SorianoJB, López-CamposJL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149:45–52. doi:10.1378/chest.15-105526291753
   PubMed Web of Science ®Google Scholar
• SinDD, MiravitllesM, ManninoDM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48:664–673. doi:10.1183/13993003.00436-201627338195
   PubMed Web of Science ®Google Scholar
• LeungJM, SinDD. Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ. 2017;358:j3772. doi:10.1136/bmj.j377228947632
   PubMed Web of Science ®Google Scholar
• SluiterHJ, KoeterGH, de MonchyJG, et al. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J. 1991;4(4):479–489.1855577
   PubMed Web of Science ®Google Scholar
• JinJ, LiuX, SunY. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res. 2014;15:130. doi:10.1186/s12931-014-0130-125359094
   PubMed Web of Science ®Google Scholar
• Oline appendix of global strategy for asthma management and prevention; 2018 Available from: http://ginasthma.org. Accessed 522, 2018.
   Google Scholar
• CataldoD, CorhayJL, DeromE, et al. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2017;12:601–613. doi:10.2147/COPD.S12445928243078
   PubMed Web of Science ®Google Scholar
• ChenFJ, LinGP, HuangXY, et al. Evaluation of the characteristics of asthma in severe and extremely severe COPD. Int J Chron Obstruct Pulmon Dis. 2019;14(3):2663–2671. doi:10.2147/COPD.S22525831819399
   PubMed Web of Science ®Google Scholar
• ChengWC, WuBR, LiaoWC, et al. Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: a real-life study. J Thorac Dis. 2018;10(6):3661–3669. doi:10.21037/jtd.2018.05.13930069364
   PubMed Web of Science ®Google Scholar
• BowatteG, LodgeCJ, LoweAJ, et al. Do variants in GSTs modify the association between traffic air pollution and asthma in adolescence? Int J Mol Sci. 2016;17(4):485. doi:10.3390/ijms1704048527043549
   PubMed Web of Science ®Google Scholar
• NadeauK, McDonald-HymanC, NothEM, et al. Ambient air pollution impairs regulatory T-cell function in asthma. J Allergy Clin Immunol. 2010;126(4):845–852. doi:10.1016/j.jaci.2010.08.00820920773
   PubMed Web of Science ®Google Scholar
• GelbAF, YamamotoA, MauadT, et al. Unsuspected mild emphysema in nonsmoking patients with chronic asthma with persistent airway obstruction. J Allergy Clin Immunol. 2014;133(1):263–265. doi:10.1016/j.jaci.2013.09.04524290280
   PubMed Web of Science ®Google Scholar
• HoggJC, ChuF, UtokaparchS, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653. doi:10.1056/NEJMoa03215815215480
   PubMed Web of Science ®Google Scholar
• CockcroftDW, WenzelS. Airway hyperresponsiveness and chronic obstructive pulmonary disease outcomes. J Allergy Clin Immunol. 2016;138:1580–1581. doi:10.1016/j.jaci.2016.06.03927516214
   PubMed Web of Science ®Google Scholar
• HodgeG, NairnJ, HolmesM, et al. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol. 2007;150(1):22–29. doi:10.1111/j.1365-2249.2007.03451.x17614970
   PubMed Web of Science ®Google Scholar
• SinghD, KolsumU, BrightlingCE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–1700. doi:10.1183/09031936.0016241425323230
   PubMed Web of Science ®Google Scholar
• JohnM, AuBT, JosePJ, et al. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol. 1998;18(1):84–90. doi:10.1165/ajrcmb.18.1.28139448049
   PubMed Web of Science ®Google Scholar
• De LlanoLP, CosíoBG, IglesiasA, et al. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018;13(12):591–601. doi:10.2147/COPD.S15369429483774
   PubMed Web of Science ®Google Scholar
• ChalmersGW, MacLeodKJ, ThomsonL, et al. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120(6):1917–1922. doi:10.1378/chest.120.6.191711742922
   PubMed Web of Science ®Google Scholar
• ZhaoX, YuFQ, HuangXJ, et al. Azithromycin influences airway remodeling in asthma via the PI3K/Akt/MTOR/HIF-1alpha/VEGF pathway. J Biol Regul Homeost Agents. 2018;32(5):1079–1088.30334401
   PubMed Web of Science ®Google Scholar
• LuHY, ZhaoGL, FuMF. Polymorphisms in the vascular endothelial growth factor (VEGF) gene associated with asthma. Genet Mol Res. 2016;15(2). doi:10.4238/gmr.15027880
   Web of Science ®Google Scholar
• ZhaW, SuM, HuangM, et al. Administration of pigment epithelium-derived factor inhibits airway inflammation and remodeling in chronic OVA-induced mice via VEGF suppression. Allergy Asthma Immunol Res. 2016;8(2):161–169. doi:10.4168/aair.2016.8.2.16126739410
   PubMed Web of Science ®Google Scholar